Regeneron Announces Presentation th Annual JPMorgan Healthcare Conference
5th Jan 2006, 21:50 GMT
Regeneron Pharmaceuticals will webcast its presentation at the 24th Annual JPMorgan Healthcare Conference on 1/9/2006.
Regeneron Announces Presentation th Annual JPMorgan Healthcare Conference related news:
- Threshold Pharmaceuticals Announces Webcast of Presentation at the 24th Annual JPMorgan Healthcare Conference — ArriveNet : Press Releases
- Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference — Pharmaceuticals News from StratCenter.com
- Biogen Idec Announces Webcast of Presentation at the 24th Annual JPMorgan Healthcare Conference — Neurology News from StratCenter.com
- Vertex Pharmaceuticals Announces Webcast of its Presentation at the 24th Annual JPMorgan Healthcare Conference — Pharmaceuticals News from StratCenter.com
- Encysive Pharmaceuticals Announces Presentation/Webcast at 24th Annual JPMorgan Healthcare Conference — RedOrbit News - Health
- XenoPort to Present at JPMorgan 24th Annual Healthcare Conference — StratWire - Business of Healthcare NewsFeed
- Alnylam to Webcast Presentation at the 24th Annual JPMorgan Healthcare Conference on 1/11/2006 — StratWire - Business of Healthcare NewsFeed
- Odyssey HealthCare to Present at the 24th Annual JPMorgan Healthcare Conference 2006 — RedOrbit News - Health
- Threshold Pharmaceuticals: Threshold Pharmaceuticals Announces Webcast of Presentation at the 24th Annual JPMorgan Healthcare Conference — Market Wire - Webcasts
- Maxygen to Present at the JPMorgan 24th Annual Healthcare Conference — Operations-Related News from StratCenter.com
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies